L2 Asset Management, LLC Ionis Pharmaceuticals Inc Transaction History

L2 Asset Management, LLC

  • $326 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$47.45 - $62.95 $1.46 Million - $1.94 Million
-30,769 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$46.85 - $61.05 $251,116 - $327,228
-5,360 Reduced 14.84%
30,769 $1.81 Million
Q1 2020

May 15, 2020
BUY
$41.6 - $63.4 $88,816 - $135,359
2,135 Added 6.28%
36,129 $1.71 Million
Q4 2019

Feb 13, 2020
BUY
$53.85 - $65.27 $1.83 Million - $2.22 Million
33,994 New
33,994 $2.05 Million

Others Institutions Holding IONS

# of Institutions
387
Shares Held
125M
Call Options Held
2.25M
Put Options Held
510K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.51B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track L2 Asset Management, LLC Portfolio

Follow L2 Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on L2 Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email